Skip to content

Cognitive and Metabolic Effects of a Probiotic Supplement

Placebo-controlled Randomized Trial of Cognitive and Metabolic Effects of a Probiotic Supplement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02005003
Enrollment
20
Registered
2013-12-09
Start date
2013-11-30
Completion date
2015-12-31
Last updated
2014-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Supplements, Probiotics, Metabolism, Food Preferences, Microbiota

Brief summary

To examine the cognitive and metabolic effects of a probiotic supplement that is readily and already available for purchase in public drug stores. This study is a double-blinded randomized cross-over placebo-controlled intervention study. Participants will be randomized to receive either the probiotic supplement or the placebo during the first intervention period which will last 2 weeks. This will be followed by a washout period, after which they will proceed to the second intervention period, also lasting 2 weeks and also followed by a washout period.

Interventions

BEHAVIORALInhibitory task

Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event

PROCEDUREBlood samples

Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit

Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period.

PROCEDURECaloric preload

A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload.

BEHAVIORALFood selection task

Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume

BEHAVIORALMemory task

Participants perform short memory tasks on each visit

BEHAVIORALFood consumption task

Participants are given a selection of food items to consume on each visit

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * Age 18-28y * Healthy (self-reported) and not on medication * Non-smoking * Normal sleep-wake rhythm (i.e. 7-8 h per night, self-reported via diaries) * Regular meal patterns with daily breakfast

Exclusion criteria

* Major illness * Taking any serious medications * Any sleep conditions (e.g. irregular bedtimes, sleep complaints) * Any dietary issues with the food items provided * Current or history of endocrine, neurological or psychiatric disorders * Shift work in the preceding three months or for a long duration * Time travel over a significant number of time zones in the preceding two months * Too much weight gain or weight loss in the preceding three months * Excessive intake of fermented dairy products * Intake of probiotics * Recent antibiotic treatment (last 6 months) * Recent intake of certain dietary supplements * Excessive caffeine (\>5 cups daily) or alcohol intake (\>2 alcohol units daily)

Design outcomes

Primary

MeasureTime frameDescription
Memory functionChange in memory function assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Memory test to examine the influence of probiotic supplement compared with placebo on memory function (declarative and working memory)

Secondary

MeasureTime frameDescription
Food preferencesChange in food preferences assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Will test whether participants food preferences are changed following each intervention, as compared with before each intervention. Test will be written and computer-based.
Inhibitory taskChange in inhibitory task performance assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event.
Glycometabolic regulationChange in glycometabolic regulation assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Glucose, insulin and other hormonal values during fasting and 1 hour following a standardized caloric preload
Sleep patternsChange in sleep patterns as assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)
Microbiome changesMicrobiome assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Changes in microbiome will be assessed following treatment with either placebo or probiotics; feces will be collected according to standardized criteria.
Food consumption taskChange in food consumption task assessed at baseline (week 0), post-intervention 1 (at week 2), pre intervention 2 (week 6), post intervention 2 (week 8) and post-washout intervention 2 (week 12)Participants will be offered a food selection and their consumption will be measured.

Countries

Sweden

Contacts

Primary ContactJonathan Cedernaes, M.D., PhD
jonathan.cedernaes@neuro.uu.se
Backup ContactChristian Benedict, PhD
christian.benedict@neuro.uu.se

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026